{{Chembox
| ImageFile = Zardaverine.svg
| ImageSize = 200px
| ImageAlt =
| IUPACName = 3-[4-(Difluoromethoxy)-3-methoxyphenyl]-1''H''-pyridazin-6-one
| OtherNames =

| Section1 = {{Chembox Identifiers
| CASNo = 101975-10-4
| PubChem = 5723
| ChemSpiderID = 5521
| InChI=1S/C12H10F2N2O3/c1-18-10-6-7(2-4-9(10)19-12(13)14)8-3-5-11(17)16-15-8/h2-6,12H,1H3,(H,16,17)
| InChIKey= HJMQDJPMQIHLPB-UHFFFAOYSA-N
| SMILES = COC1=C(C=CC(=C1)C2=NNC(=O)C=C2)OC(F)F
  }}

|Section2={{Chembox Properties
| C=12 | H=10 | F=2 | N=2 | O=3
| Appearance = 
| Density = 
| MeltingPt = 
| BoilingPt = 
| Solubility =
  }}

| Section3 = {{Chembox Hazards
| MainHazards = 
| FlashPt = 
| AutoignitionPt =
  }}
}}

'''Zardaverine''' is a dual-selective [[Phosphodiesterase 3|PDE3]]/[[Phosphodiesterase 4|4]] [[phosphodiesterase inhibitor]].<ref>{{cite journal | pmid = 22891752 | year = 2012 | last1 = Kümmerle | first1 = AE | last2 = Schmitt | first2 = M | last3 = Cardozo | first3 = SV | last4 = Lugnier | first4 = C | last5 = Villa | first5 = P | last6 = Lopes | first6 = AB | last7 = Romeiro | first7 = NC | last8 = Justiniano | first8 = H | last9 = Martins | first9 = MA | last10 = Fraga | first10 = CA | last11 = Bourguignon | first11 = JJ | last12 = Barreiro | first12 = EJ | title = Design, Synthesis, and Pharmacological Evaluation of ''N''-Acylhydrazones and Novel Conformationally Constrained Compounds as Selective and Potent Orally Active Phosphodiesterase-4 Inhibitors | volume = 55 | issue = 17 | pages = 7525–45 | doi = 10.1021/jm300514y | journal = Journal of Medicinal Chemistry}}</ref>

==References==
{{reflist}}

{{Phosphodiesterase inhibitors}}

[[Category:Phosphodiesterase inhibitors]]

{{organic-compound-stub}}